Analysts at MLV & Co. initiated coverage on Evoke Pharma EVOK with a Buy rating.
The target price for Evoke Pharma is set to $12.50.
Evoke Pharma shares have dropped 31.96% over the past 52 weeks, while the S&P 500 index has gained 14.72% in the same period.
Evoke Pharma's shares rose 0.15% to close at $6.62 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in